They will also take into consideration whether the patient is on other drugs that might be obesogenic, meaning causing weight gain, or if they are using an FDA-approved GLP-1 drug versus a compounded medication, which can have variable quality and unknown efficacy
These positive changes reinforce adherence and help patients stay invested in the gradual, sustainable nature of the program
I see many patients who say, Ill just wait for the new triple drug. As a doctor, I strongly advise against this strategy for three reasons: Obesity is a progressive disease
The Disappearance of Food Noise One of the most profound effects reported by patients is the silencing of food noise. This refers to the constant, intrusive thoughts about food, cravings, and the next meal that many people with metabolic struggles experience
Consistent release of medication for optimal results
As evidence matures, it is anticipated that clinical guidelines will be developed to support safe and effective use of retatrutide, should it receive regulatory approval
